UBS sells all shares in Neurosearch
Few days after becoming a major shareholder in the Danish biotech company, Neurosearch, Swiss bank UBS is selling all its shares again. It is not the first time the bank has used the tactic.
by Leonora Beck
Swiss bank UBS announced Wednesday the sale of its shares in Neurosearch, reducing its ownership share to zero. It is no more than five days since the bank bought a total of 2,025,619 shares in the Danish biotech, giving them an 8.25 % stake in the company.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
